Benzinga’s Top Ratings Upgrades, Downgrades For December 13, 2022
Upgrades For Equinix Inc (NASDAQ:EQIX), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In…
Jefferies Initiates Coverage On VectivBio Holding with Buy Rating, Announces Price Target of $18
Jefferies analyst Chris Howerton initiates coverage on VectivBio Holding (NASDAQ:VECT) with a Buy rating and announces Price Target of $18.
Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday
Gainers
Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.
Albertsons Companies, Domino’s Pizza And Other Big Gainers From Thursday
U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session.
SVB Leerink Maintains Outperform on VectivBio Holding, Raises Price Target to $30
SVB Leerink analyst Thomas Smith maintains VectivBio Holding (NASDAQ:VECT) with a Outperform and raises the price target from $28 to $30.
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers
FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
71 Biggest Movers From Yesterday
Gainers
Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 225% to close at $4.68 on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sidus Space, Inc. (NASDAQ: SIDU) shares surged 92.4% to $2.77 after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
VectivBio Reports Japanese License Deal, Loan Facility Providing Up To $117M In Financing
Exclusive License with Asahi Kasei Pharma to develop and commercialize Apraglutide in Japan includes $30 million upfront cash payment, eligibility for up to $170 million in development and commercial milestones and
VectivBio Announces Japan License Deal And Loan Facility Agreement, Providing Up To $117M To ‘Fuel The Company Through Key Catalysts’
VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts
•Exclusive License with Asahi Kasei Pharma to develop and commercialize